410 related articles for article (PubMed ID: 33649592)
1. Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion.
Frangieh CJ; Melms JC; Thakore PI; Geiger-Schuller KR; Ho P; Luoma AM; Cleary B; Jerby-Arnon L; Malu S; Cuoco MS; Zhao M; Ager CR; Rogava M; Hovey L; Rotem A; Bernatchez C; Wucherpfennig KW; Johnson BE; Rozenblatt-Rosen O; Schadendorf D; Regev A; Izar B
Nat Genet; 2021 Mar; 53(3):332-341. PubMed ID: 33649592
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion.
Freeman AJ; Vervoort SJ; Ramsbottom KM; Kelly MJ; Michie J; Pijpers L; Johnstone RW; Kearney CJ; Oliaro J
Cell Rep; 2019 Sep; 28(11):2784-2794.e5. PubMed ID: 31509742
[TBL] [Abstract][Full Text] [Related]
3. The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity.
Ho P; Melms JC; Rogava M; Frangieh CJ; Poźniak J; Shah SB; Walsh Z; Kyrysyuk O; Amin AD; Caprio L; Fullerton BT; Soni RK; Ager CR; Biermann J; Wang Y; Khosravi-Maharlooei M; Zanetti G; Mu M; Fatima H; Moore EK; Vasan N; Bakhoum SF; Reiner SL; Bernatchez C; Sykes M; Mace EM; Wucherpfennig KW; Schadendorf D; Bechter O; Shah P; Schwartz GK; Marine JC; Izar B
Cancer Cell; 2023 Jul; 41(7):1207-1221.e12. PubMed ID: 37327789
[TBL] [Abstract][Full Text] [Related]
4. From patient tissue correlates to molecular mechanisms of cancer immune evasion: the emerging role of CD58 and PD-L1 co-regulation via CMTM6.
Melms JC; Ho P; Rogava M; Izar B
Genes Immun; 2024 Feb; 25(1):82-84. PubMed ID: 38082156
[TBL] [Abstract][Full Text] [Related]
5. In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.
Dubrot J; Du PP; Lane-Reticker SK; Kessler EA; Muscato AJ; Mehta A; Freeman SS; Allen PM; Olander KE; Ockerman KM; Wolfe CH; Wiesmann F; Knudsen NH; Tsao HW; Iracheta-Vellve A; Schneider EM; Rivera-Rosario AN; Kohnle IC; Pope HW; Ayer A; Mishra G; Zimmer MD; Kim SY; Mahapatra A; Ebrahimi-Nik H; Frederick DT; Boland GM; Haining WN; Root DE; Doench JG; Hacohen N; Yates KB; Manguso RT
Nat Immunol; 2022 Oct; 23(10):1495-1506. PubMed ID: 36151395
[TBL] [Abstract][Full Text] [Related]
6. Cancer cell-intrinsic resistance to BiTE therapy is mediated by loss of CD58 costimulation and modulation of the extrinsic apoptotic pathway.
Shen Y; Eng JS; Fajardo F; Liang L; Li C; Collins P; Tedesco D; Nolan-Stevaux O
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35296559
[TBL] [Abstract][Full Text] [Related]
7. SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA.
Wu R; Wang C; Li Z; Xiao J; Li C; Wang X; Kong P; Cao J; Huang F; Li Z; Huang Y; Chen Y; Li X; Yang D; Zhang H; Mai J; Feng G; Deng R; Zhu X
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33158915
[TBL] [Abstract][Full Text] [Related]
8. Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58.
Veldman J; Visser L; Huberts-Kregel M; Muller N; Hepkema B; van den Berg A; Diepstra A
Blood; 2020 Nov; 136(21):2437-2441. PubMed ID: 32589698
[TBL] [Abstract][Full Text] [Related]
9. Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens.
Dixit A; Parnas O; Li B; Chen J; Fulco CP; Jerby-Arnon L; Marjanovic ND; Dionne D; Burks T; Raychowdhury R; Adamson B; Norman TM; Lander ES; Weissman JS; Friedman N; Regev A
Cell; 2016 Dec; 167(7):1853-1866.e17. PubMed ID: 27984732
[TBL] [Abstract][Full Text] [Related]
10. Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions.
Sucker A; Zhao F; Pieper N; Heeke C; Maltaner R; Stadtler N; Real B; Bielefeld N; Howe S; Weide B; Gutzmer R; Utikal J; Loquai C; Gogas H; Klein-Hitpass L; Zeschnigk M; Westendorf AM; Trilling M; Horn S; Schilling B; Schadendorf D; Griewank KG; Paschen A
Nat Commun; 2017 May; 8():15440. PubMed ID: 28561041
[TBL] [Abstract][Full Text] [Related]
11. LATS1/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression.
Yang Q; Lv Z; Wang M; Kong M; Zhong C; Gao K; Wan X
J Exp Clin Cancer Res; 2024 Feb; 43(1):54. PubMed ID: 38383447
[TBL] [Abstract][Full Text] [Related]
12. Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells.
Mimitou EP; Cheng A; Montalbano A; Hao S; Stoeckius M; Legut M; Roush T; Herrera A; Papalexi E; Ouyang Z; Satija R; Sanjana NE; Koralov SB; Smibert P
Nat Methods; 2019 May; 16(5):409-412. PubMed ID: 31011186
[TBL] [Abstract][Full Text] [Related]
13. Tumor immune evasion arises through loss of TNF sensitivity.
Kearney CJ; Vervoort SJ; Hogg SJ; Ramsbottom KM; Freeman AJ; Lalaoui N; Pijpers L; Michie J; Brown KK; Knight DA; Sutton V; Beavis PA; Voskoboinik I; Darcy PK; Silke J; Trapani JA; Johnstone RW; Oliaro J
Sci Immunol; 2018 May; 3(23):. PubMed ID: 29776993
[TBL] [Abstract][Full Text] [Related]
14. EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas.
Otsuka Y; Nishikori M; Arima H; Izumi K; Kitawaki T; Hishizawa M; Takaori-Kondo A
Mol Immunol; 2020 Mar; 119():35-45. PubMed ID: 31962268
[TBL] [Abstract][Full Text] [Related]
15. Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma.
Effern M; Glodde N; Braun M; Liebing J; Boll HN; Yong M; Bawden E; Hinze D; van den Boorn-Konijnenberg D; Daoud M; Aymans P; Landsberg J; Smyth MJ; Flatz L; Tüting T; Bald T; Gebhardt T; Hölzel M
Immunity; 2020 Sep; 53(3):564-580.e9. PubMed ID: 32750334
[TBL] [Abstract][Full Text] [Related]
16. CD58 Immunobiology at a Glance.
Zhang Y; Liu Q; Yang S; Liao Q
Front Immunol; 2021; 12():705260. PubMed ID: 34168659
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors.
Kakavand H; Rawson RV; Pupo GM; Yang JYH; Menzies AM; Carlino MS; Kefford RF; Howle JR; Saw RPM; Thompson JF; Wilmott JS; Long GV; Scolyer RA; Rizos H
Clin Cancer Res; 2017 Oct; 23(20):6054-6061. PubMed ID: 28724663
[No Abstract] [Full Text] [Related]
18. Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity.
Melms JC; Vallabhaneni S; Mills CE; Yapp C; Chen JY; Morelli E; Waszyk P; Kumar S; Deming D; Moret N; Rodriguez S; Subramanian K; Rogava M; Cartwright ANR; Luoma A; Mei S; Brinker TJ; Miller DM; Spektor A; Schadendorf D; Riggi N; Wucherpfennig KW; Sorger PK; Izar B
Cancer Res; 2020 Feb; 80(4):798-810. PubMed ID: 31882401
[TBL] [Abstract][Full Text] [Related]
19. Model-based understanding of single-cell CRISPR screening.
Duan B; Zhou C; Zhu C; Yu Y; Li G; Zhang S; Zhang C; Ye X; Ma H; Qu S; Zhang Z; Wang P; Sun S; Liu Q
Nat Commun; 2019 May; 10(1):2233. PubMed ID: 31110232
[TBL] [Abstract][Full Text] [Related]
20. A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response.
Adamson B; Norman TM; Jost M; Cho MY; Nuñez JK; Chen Y; Villalta JE; Gilbert LA; Horlbeck MA; Hein MY; Pak RA; Gray AN; Gross CA; Dixit A; Parnas O; Regev A; Weissman JS
Cell; 2016 Dec; 167(7):1867-1882.e21. PubMed ID: 27984733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
